Concepedia

Mathieu Métifiot

MM

Statistics

Publications

33

Citations

1.6K

H-Index

27

Active since

2005

Affiliations

National Cancer Institute(Current)

National Institutes of Health

Center for Cancer Research

Université de Bordeaux

Frederick National Laboratory for Cancer Research

Mathieu Métifiot is an author at National Cancer Institute specializing in antiretroviral therapy, antiviral pharmacology, and antiviral agents.

ORCID

Publications per year

2005–2022

33

Publications

33

Structural and Functional Analyses of the Second-Generation Integrase Strand Transfer Inhibitor Dolutegravir (S/GSK1349572)

S. Hare, Steven J. Smith, Mathieu Métifiot et al. · Molecular Pharmacology · 2011 · 258 citations · Full text

, , +17

Resistance to Integrase Inhibitors

Mathieu Métifiot, Christophe Marchand, Kasthuraiah Maddali et al. · Viruses · 2010 · 97 citations · Full text

, , +17

Elvitegravir overcomes resistance to raltegravir induced by integrase mutation Y143

Mathieu Métifiot, Nick Vandegraaff, Kasthuraiah Maddali et al. · AIDS · 2011 · 78 citations · Full text

, , +17

Structure–Activity Relationship of Pyrrolyl Diketo Acid Derivatives as Dual Inhibitors of HIV-1 Integrase and Reverse Transcriptase Ribonuclease H Domain

Giuliana Cuzzucoli Crucitti, Mathieu Métifiot, Luca Pescatori et al. · Journal of Medicinal Chemistry · 2015 · 76 citations · Full text

, , +17

Biochemical and Pharmacological Analyses of HIV-1 Integrase Flexible Loop Mutants Resistant to Raltegravir

Mathieu Métifiot, Kasthuraiah Maddali, Alena Naumova et al. · Biochemistry · 2010 · 67 citations · Full text

, , +17

1–5 of 33